TUESDAY, Jan. 21, 2025 (HealthDay News) -- Hormone replacement therapy to ease menopause symptoms doesn’t increase a woman’s risk of brain tumors. Researchers found no link between hormone therapy and ...

The FDA approved datopotamab deruxtecan-dlnk for treatment of certain patients with advanced breast cancer.The indication ...

On January 17, 2025, the Food and Drug Administration (FDA) approved datopotamab deruxtecan-dlnk a Trop-2-directed antibody ...

Menopause is a chapter in women’s lives that brings a myriad of sometimes debilitating medical issues that can last for more ...

Research suggests a new drug slowed the growth of prostate cancer cells, including those with a resistance to the hormone ...

"Boy Meets World" star Danielle Fishel said she is finished with radiation treatment for cancer and opened up about the side ...

The clearance of Datroway comes months after the companies narrowed approval plans in lung cancer and opens up a market ...

Prostate cancer presents challenges in detection, treatment, and management. Learn about genetic risks, treatment resistance, ...

Hormone therapy does not appear to increase the risk of glioma among women in the United States, data suggest.

A new research paper was published in Aging (listed by MEDLINE/PubMed as "Aging (Albany NY)" and "Aging-US" by Web of Science) on December 5, 2024, Volume 16, Issue 22, titled "DNA-methylation age and ...